Helsinn
Helsinn is a subsidiary of global pharmaceutical company Helsinn.
Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals, with the recent additions of medical devices in therapeutic niche areas.
Financial Data
-
31st Dec 17 Source: CRO
- €168.2 million turnover
-
€14.8 million
profit - 182 employees
-
31st Dec 16 Source: CRO
- €245.1 million turnover
-
€80.2 million
profit - 177 employees
- 6 more years available »
Ranking
By Turnover
(€168.2 million)- 346th in Top Companies
- 39th in Pharma
By Employees
(182)- 586th in Top Companies
- 57th in Pharma
-
- 182
- €168.2 million
Employees
- Padraig Summers CEO/Managing Director
Latest News
- 2:09pm No-deal Brexit would be ‘absolutely catastrophic’, Airbus boss warns
- 1:49pm Citigroup makes offer to buy London skyscraper HQ for €1.37 bn
- 1:19pm Seen & Heard: Consultancy companies in firing line over children’s hospital
- Feb 16 UK airline Flybmi blames Brexit uncertainty for its collapse
- Feb 16 Derry airport ‘reviewing options’ over Stansted route as flybmi collapses